# mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

> **NCT06919796** · PHASE2 · NOT_YET_RECRUITING · sponsor: **PharmaJet, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy Volunteers
- SARS CoV-2

## Interventions

- **BIOLOGICAL:** COMIRNATY®

## Key facts

- **NCT ID:** NCT06919796
- **Lead sponsor:** PharmaJet, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-11-25
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06919796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06919796, "mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06919796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*